Se-Methyl-Seleno-L-Cysteine, Rituximab, Ifosfamide, Carboplatin, and Etoposide in Treating Patients With Diffuse Large B-Cell Lymphoma That Has Relapsed or Not Responded to Treatment

NCT00829205 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Conditions

Lymphoma

Interventions

BIOLOGICAL: filgrastim
BIOLOGICAL: rituximab
DIETARY_SUPPLEMENT: Se-methyl-seleno-L-cysteine
DRUG: carboplatin
DRUG: etoposide
DRUG: ifosfamide
OTHER: laboratory biomarker analysis
OTHER: pharmacological study

Sponsor

Cancer Research UK